BioHarvest Sciences Inc. (CSE: BHSC)

Market Cap	151.10M
Revenue (ttm)	26.18M
Net Income (ttm)	-22.21M
Shares Out	17.33M
EPS (ttm)	-1.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,650
Open	8.80
Previous Close	8.75
Day's Range	8.55 - 8.80
52-Week Range	5.78 - 10.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BioHarvest Sciences

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness produc...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Ilan Sobel
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BHSC

Financial Performance

In 2023, BioHarvest Sciences's revenue was $12.67 million, an increase of 130.48% compared to the previous year's $5.50 million. Losses were -$12.56 million, 11.8% more than in 2022.

Financial numbers in USD